HLA-B27 is a potential risk factor for posttransplantation diabetes mellitus in autosomal dominant polycystic kidney disease patients
- PMID: 21094798
- DOI: 10.1016/j.transproceed.2010.08.046
HLA-B27 is a potential risk factor for posttransplantation diabetes mellitus in autosomal dominant polycystic kidney disease patients
Abstract
The aim of this work was to investigate HLA phenotype predisposition to posttransplantation diabetes mellitus (PTDM) in kidney transplant recipients stratified according to kidney failure etiology. Ninety-eight transplant recipient pairs with kidney grafts from the same cadaveric donor were qualified for the study. In each pair, 1 kidney was grafted to an individual with autosomal dominant polycystic kidney disease (ADPKD group) and 1 to recipient with a different cause of kidney failure (non-ADPKD group). All class II HLA antigens were determined with the PCR-SSP molecular method. To identify class I HLA molecules we used both molecular and serologic methods. Diabetes was diagnosed according to the American Diabetes Association criteria. The posttransplantation observation period was 12 months. In the ADPKD group, HLA-B27 was more common in PTDM than non-PTDM patients; 31.6% versus 11.4% (P = .069). The difference achieved significance when comparing insulin-treated with non-insulin-treated patients (44.4% vs 12.4%; P = .029). In the non-ADPKD group, HLA-A28 and HLA-B13 were observed more frequently in patients with PTDM than in recipients without diabetes (22.2% vs 2.5% [P = .0099] and 22.2% vs 3.8% [P = .020]). All of these associations were significant upon multivariate analysis. HLA-B27 allele is a factor predisposing ADPKD patients to insulin-dependent PTDM. Antigens predisposing to PTDM among kidney graft recipients without ADPKD include HLA-A28 and B13.
Copyright © 2010 Elsevier Inc. All rights reserved.
Similar articles
-
Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation.Ann Acad Med Stetin. 2008;54(1):41-8. Ann Acad Med Stetin. 2008. PMID: 19127808
-
Autosomal-dominant polycystic kidney disease and kidney transplantation: experience of a single center.Transplant Proc. 2009 Apr;41(3):887-90. doi: 10.1016/j.transproceed.2009.01.069. Transplant Proc. 2009. PMID: 19376380
-
New onset diabetes after kidney transplantation in autosomal dominant polycystic kidney disease: a retrospective cohort study.Nephrology (Carlton). 2012 Jan;17(1):89-96. doi: 10.1111/j.1440-1797.2011.01507.x. Nephrology (Carlton). 2012. PMID: 21854501
-
Transplantation of a cadaveric polycystic kidney in a patient with autosomal dominant polycystic kidney disease: long-term outcome.Transplant Proc. 2004 Jun;36(5):1288-92. doi: 10.1016/j.transproceed.2004.05.003. Transplant Proc. 2004. PMID: 15251314 Review.
-
[Post-transplant diabetes mellitus: diagnosis and treatment].G Ital Nefrol. 2007 Nov-Dec;24(6):547-57. G Ital Nefrol. 2007. PMID: 18278758 Review. Italian.
Cited by
-
HLA Alleles Cw12 and DQ4 in Kidney Transplant Recipients Are Independent Risk Factors for the Development of Posttransplantation Diabetes.Transplant Direct. 2021 Jul 23;7(8):e737. doi: 10.1097/TXD.0000000000001188. eCollection 2021 Aug. Transplant Direct. 2021. PMID: 35836669 Free PMC article.
-
New onset diabetes after kidney transplantation in patients with autosomal dominant polycystic kidney disease: systematic review protocol.BMJ Open. 2015 Nov 5;5(11):e008440. doi: 10.1136/bmjopen-2015-008440. BMJ Open. 2015. PMID: 26546139 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials